Quorum vs Veeva Vault Safety
Veeva is a serious safety system with real customers in our segment, and this page is not going to pretend otherwise. The honest question is narrower than “which is better”: it is what the case-processing work looks like day to day, and what you can find out about the price before you take a call.
Things we will not pretend otherwise about. Veeva publishes an eight-week accelerated implementation for small biotechs, with a named customer — Bellerophon Therapeutics configured, validated and trained in that window. Its Case Intake and Case Narrative agents are generally available now, not roadmap. It ships a real validation package with every release: validation plan, requirements, test protocols, IQ/OQ, traceability matrix, summary report. And a biotech planning to run Veeva across clinical, quality and regulatory gets integration value we cannot match. If you read a comparison page claiming Veeva is slow, has no AI, or leaves validation to you, stop reading it.
| DIMENSION | Quorum | Veeva Vault Safety |
|---|---|---|
| Pricing transparency | Published on this website — platform fee, included band, per-case rate | Not published; quoted per contract1 |
| Per-user fees | None — add your safety team, Quality, and your QPPV | Vault is licensed per application plus named users1 |
| Where AI sits in the case | Across the whole chain — extraction, MedDRA coding, seriousness, narrative | Two generally available agents: Case Intake (extraction) and Case Narrative (drafting and readability)2 |
| Provenance on AI output | Field-level — click any generated value for the exact source sentence | Document-level — the source inbox item links bidirectionally to the case record3 |
| Time to validated go-live | Weeks | Eight weeks on the accelerated “Essentials” path, evidenced by a named customer4 |
| Validation package | GAMP 5 package included, re-issued each qualified release | Validation plan, requirements, test protocols, IQ/OQ, traceability matrix and summary report per release; the customer owns PQ5 |
| Emerging-biotech packaging | Safety is the whole product | Standard Vault Safety plus an accelerated services package — Vault Safety is not part of the lower-cost Veeva Basics line6 |
| Proven at scale | Early — ask us for design-partner references | Far ahead: AbbVie migrated 6M cases and 17M documents; UCB runs global PV on the Safety Suite4 |
- Veeva does not publish Vault Safety pricing. Structure — per-application subscription plus named users — is described in third-party analysis; no vendor-published figure exists for any safety database, ours excepted. · checked 27 Jul 2026
- Veeva — “Veeva Brings Artificial Intelligence to Drug Safety”: Case Intake Agent and Case Narrative Agent listed as available today · checked 27 Jul 2026
- Veeva Vault Safety help documentation — inbox item source document links to the generated case record · checked 27 Jul 2026
- Veeva — accelerated implementation model: “small biotechs can implement a safety solution in only 8 weeks”, with the Bellerophon Therapeutics customer story · checked 27 Jul 2026
- Veeva — Vault validation product brief: validation project plan, requirements, test protocol, IQ/OQ, traceability matrices and validation summary report per release · checked 27 Jul 2026
- Veeva — “Veeva Basics Adopted by More Than 100 Emerging Biotechs” (4 Nov 2025): Basics spans quality, regulatory, clinical, medical and commercial; Safety is not among the listed applications · checked 27 Jul 2026
Choose Veeva Vault Safety if…
You are already on Vault, or you expect to be. If eTMF, QMS and regulatory submissions are going to run on Veeva, keeping safety in the same platform is a genuine advantage — one vendor, one audit trail, one integration surface. You also get a company that has survived migrations at AbbVie scale, a deep partner ecosystem, and a disciplined three-releases-a-year cadence that Quality teams like. If your board wants the safe institutional choice, this is it, and we would not argue hard against that.
Choose Quorum if…
You want to know the price before the call, and you want to add every reviewer, your Quality lead and your QPPV without a per-seat conversation. And you want AI across the whole case rather than at two points in it — with provenance at the level of the individual field, so a reviewer approving a MedDRA code or a seriousness assessment sees the sentence behind it, not just the document it came from.
The distance between us on speed and validation is smaller than a comparison page would normally admit, and we would rather you heard that here than from their rep. Where we actually differ is coverage of AI across the case, provenance at field level, and the fact that our price is on this website.
Common questions.
- How fast can Veeva Vault Safety be implemented?
- Veeva publishes an eight-week accelerated implementation for small biotechs and backs it with a named customer story — Bellerophon Therapeutics, configured, validated and trained in that window. Larger migrations take far longer; AbbVie’s ran to fifteen months. Anyone telling you Veeva is inherently slow is describing the enterprise case, not the biotech one.
- Does Veeva have AI for case processing?
- Yes. The Case Intake Agent handles data extraction from source documents and flags anomalies, and the Case Narrative Agent drafts and improves narratives. Both are generally available. The difference we would point to is coverage across the whole case and provenance at field rather than document level — not the presence or absence of AI.
- Is Vault Safety part of Veeva Basics?
- Not according to Veeva’s November 2025 announcement, which lists Basics applications across quality, regulatory, clinical, medical and commercial without a safety module. Veeva does sell standard Vault Safety into this segment with an accelerated services package. If that changes, tell us and we will update this page.
- What does Veeva Vault Safety cost?
- Veeva does not publish it. Neither does any other safety database vendor we could find, which is why we publish ours.
See the difference on a real case.
Bring one of your own, de-identified. Thirty minutes, end to end.